CDKN1A and neoplasm: In TH-MYCN mice DFMO administration resulted in an increased expression of cyclin-dependent kinase inhibitor 1, p21Cip1, a protein normally repressed in neuroblastoma, also resulting in cell cycle arrest and prevention of tumor cell migration and invasion of tumor cells [85,89].